PVA Editor | US Medical Innovations

Canady Cold Plasma Conversion System Treatment: An Effective Inhibitor of Cell Viability in Breast Cancer Molecular Subtypes

by PVA Editor | Aug 31, 2020 | Cold Plasma, Publications, Uncategorized

Canady Cold Plasma Conversion System Treatment: An Effective Inhibitor of Cell Viability in Breast Cancer Molecular Subtypes By Lawan Ly, Xiaoqian Cheng, Saravana R K Murthy, Taisen Zhuang (Supervision), Olivia Z Jones (Writing – review and editing), Giacomo Basadonna...

JCRI-ABTS Seeks FDA Emergency Use Authorization for the Canady Helios Cold Plasma HERO System for the Treatment of COVID-19

by PVA Editor | Apr 29, 2020 | News Release, News Release 2020

Takoma Park, MD Read Press...

Canady Helios Cold Plasma Scalpel Successfully Used by Chaim Sheba Medical Center Surgeons to Remove Inoperable Retroperitoneal Cancer

by PVA Editor | Jan 30, 2020 | News Release 2020

Canady Helios Cold Plasma Scalpel Successfully Used by Chaim Sheba Medical Center Surgeons to Remove Inoperable Retroperitoneal Cancer Read Press...

Scientific American Top Ten Emerging Technologies of 2019: Canady Cold Plasma

by PVA Editor | Dec 20, 2019 | General, Publications

Plasma Power: New Supercharged Scalpel Takes On Cancer By Mark Peplow PhD Read...

Reduced Blood Loss With Use of Canady Hybrid Plasma Scalpel Compared With Bovie Electrocautery in the Resection of Soft-Tissue Sarcomas

by PVA Editor | Dec 18, 2019 | General, Publications

Connor J. Wakefield, BS, Chris Culvern, MS, Matthew W. Colman, MD, Jerome Canady, MD, Steven Gitelis, MD, Alan T. Blank, MD, MS Read...

« Older Entries

Next Entries »